Expression of BAF57 in ovarian cancer cells and drug sensitivity.
about
In vitro evaluation of a combination treatment involving anticancer agents and an aurora kinase B inhibitorThe developmental and pathogenic roles of BAF57, a special subunit of the BAF chromatin-remodeling complex.Lovastatin induced Kruppel like factor 2 (KLF2), Kruppel like factor 6 (KLF6) and Ras homolog family member B (RHOB) genes and preferentially led to viability reduction of Cisplatin-resistant cells.Multiregion whole-exome sequencing of matched primary and metastatic tumors revealed genomic heterogeneity and suggested polyclonal seeding in colorectal cancer metastasis.Over-activation of AKT signaling leading to 5-Fluorouracil resistance in SNU-C5/5-FU cells.
P2860
Expression of BAF57 in ovarian cancer cells and drug sensitivity.
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Expression of BAF57 in ovarian cancer cells and drug sensitivity.
@ast
Expression of BAF57 in ovarian cancer cells and drug sensitivity.
@en
type
label
Expression of BAF57 in ovarian cancer cells and drug sensitivity.
@ast
Expression of BAF57 in ovarian cancer cells and drug sensitivity.
@en
prefLabel
Expression of BAF57 in ovarian cancer cells and drug sensitivity.
@ast
Expression of BAF57 in ovarian cancer cells and drug sensitivity.
@en
P2093
P2860
P356
P1433
P1476
Expression of BAF57 in ovarian cancer cells and drug sensitivity.
@en
P2093
Hiroto Izumi
Junichi Tsukada
Kazuto Nishio
Takahiro Yamaguchi
Tomoko Kurita
Toru Hachisuga
Yasuo Morimoto
Yoshiko Iwai
P2860
P304
P356
10.1111/CAS.12612
P577
2015-02-25T00:00:00Z